Happy New Year!
Dr. Weiner’s blog will return next week.
|
|
Spring Semester 2022 Public Health Update
With the emergence and rapid spread of the Omicron variant of COVID-19, the university has revised its public health guidelines for the spring 2022 semester. View the full guidelines on the Public Health and University Operations webpage. Of note:
- Spring semester will begin as scheduled and will use virtual instruction through January 30. In-person classes across the university are planned to resume on Monday, January 31.
- In the period before January 31, staff members who are able to telework are encouraged to do so as much as possible.
- When research activities require in-person work, research faculty and staff should consider scheduling work in such a way that allows for reduced density, maintain physical distancing when possible and wear a properly-fitted, high-grade mask (e.g., N95, KN95, KF94) inside at all times.
-
Students, faculty and staff will need to get tested prior to their arrival on campus after the winter break, regardless of their vaccination status or whether they have traveled or remained in the local area. Learn more about spring 2022 arrival testing.
|
|
COVID-19 Booster Shots Required by January 21
Georgetown University requires students, faculty, staff and visitors to be fully vaccinated against COVID-19 and, effective January 21, to have received a COVID-19 vaccine booster shot, or to have an approved medical or religious exemption. Those who have been vaccinated recently and are not yet eligible to get a booster shot will receive a deadline extension until they are eligible, at which time they will need to get a booster shot. Read more about Georgetown’s COVID-19 vaccination requirement.
|
|
Tumor Biology Program Student Selected as Presidential Management Fellow
David Zahavi (G’22), a doctoral candidate in the Tumor Biology Program working under the mentorship of Georgetown Lombardi Director Louis Weiner, MD, has been named as a finalist in the Presidential Management Fellows (PMF) program, a two-year leadership development program that matches outstanding graduate students with employment opportunities in the federal government. As a PMF finalist, Zahavi plans to pursue an opportunity with either the NIH or NSF.
|
|
MedStar Health and Georgetown University Medical Center to Develop Artificial Intelligence and Machine Learning Training for Early Career and Minority Investigators Interested in Health Disparities
MedStar Health and Georgetown University Medical Center announce their collaboration in the Data Science Training Core, part of a new two-year, multimillion-dollar award funded by the National Institutes of Health (NIH). The initiative is one of the four core functions of the Artificial Intelligence/Machine Learning (AI/ML) Consortium to Advance Health Equity and Researcher Diversity (AIM-AHEAD) Program. Read more about this collaboration.
|
|
Call for Proposals: RADIANCE Grants
The Office of Faculty and Academic Affairs is pleased to announce a request for proposals focused on diversity, equity, inclusion and anti-racism through the newly launched RADIANCE Grants Program. RADIANCE Grants (Respect, Advocacy, Diversity, Inclusion, ANti-racism, Collaboration, Equity) aim to contribute to a culture of respect, inclusion and belonging through strategies that promote advocacy, diversity, anti-racism, collaboration and/or equity. View the Call for Proposals and the Application Portal. Deadline for proposal submission: January 31, 5:00 p.m. EST. Three information sessions about the grant program will be held via Zoom on January 12, 12:00 - 1:00 p.m., January 20, 5:00 - 6:00 p.m. and January 25, 9:00 - 10:00 p.m.
|
|
Big Data Training for Cancer Research
Big Data Training for Cancer Research, offered by Purdue University Center for Cancer Research and Indiana University Simon Comprehensive Cancer Center, is a 14-day National Cancer Institute-funded virtual workshop to help cancer researchers develop skills for managing, visualizing, analyzing and integrating various types of omics data in cancer studies. To be held May 13 - 27, the workshop is open to cancer researchers, including oncologists, faculty, postdoctoral researchers and graduate students, who can commit to the full 14 days. Individuals from underrepresented groups are especially encouraged to apply. Note: The workshop may also be offered on-site at Purdue University in West Lafayette, Ind., depending on the COVID-19 situation. Read more about the workshop. Application deadline is Tuesday, February 1. View the application.
|
|
Thursday, January 6
4:00 - 5:00 p.m.
John Cijiang He, MD, PhD, professor, medicine, nephrology, and professor, pharmacological sciences, Icahn School of Medicine at Mount Sinai, presents “Development of New Therapies for Diabetic Kidney Disease.” Note: CME/CE credit may be offered for this seminar. Join the Dean’s Seminar via Zoom.
|
|
Friday, January 7
12:00 - 1:00 p.m.
Blair Christian, PhD, research scientist in the Biomedical, Engineering, and Computing Group at Oak Ridge National Laboratories with a joint appointment at University of Tennessee, presents “Social and Environmental Determinants of Health for Population Health and Precision Medicine.” Co-sponsored by GHUCCTS and MedStar Health Research Institute. Join Grand Rounds via Zoom.
|
|
Monday, January 10
10:00 - 11:00 a.m.
Via Zoom
Learn how to upload your CV, add your personal website information, upload a syllabus, publications and more. Register for this class.
|
|
Funding and Award Opportunities
Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program
The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program (BMSF DCTCDP) is a two-year program designed to support the career development of early-stage investigator (as defined by NIH) physicians underrepresented in medicine, or physicians who have a demonstrated commitment to increasing diversity in clinical research, to become independent clinical trial investigators who are engaged in advancing health equity through their research and mentoring. Awardees receive $120K/year for two years; requires at least 40% of the scholar’s time. View more information. LOI deadline: Jan. 14. Application opens (by invitation only): Jan. 31.
_______________________________
Mary Kay Ash Foundation 2022 Cancer Research Grants
The Mary Kay Ash Foundation, a funding source for cancer research, is currently accepting applications for innovative grants for translational research for cancers affecting women, including but not limited to ovarian, uterine, breast and/or cervical cancer. Principal Investigator must be appointed a full-time assistant professor or higher at the time of application submission and commit a minimum 5% effort. Grants will be awarded in the amount of $100,000 over a two-year period. View more information. Please submit grant documentation to Sharon Levy (sgl5@georgetown.edu) by Jan. 21.
_______________________________
Damon Runyon Clinical Investigator Award
The Damon Runyon Clinical Investigator Award supports the most promising early career physician-scientists willing to devote their efforts to the development and application of new diagnostic approaches and therapeutic strategies for cancer and cancer prevention through clinical investigation. Preference is given to those whose research adheres to the “Handshake Rule,” meaning that the physician will conduct research studies that directly involve patients. The award will provide $600,000 over three years in financial support for the investigator’s scientific needs. In addition, the foundation will retire up to $100,000 of medical school debt owed by the awardee. Five nominations will be accepted for review from Georgetown Lombardi. Finalists will be invited to be interviewed by the selection committee. Only one application will be accepted from a mentor (including co-mentorships) or investigator per review session. View detailed award information, eligibility criteria, application guidelines and forms. Application deadline: Feb. 1.
|
|
Meetings in italics should be attended by all fellows.
|
|
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)
12:15 PM | Holiday Block | Podium A / Zoom (dial 646-558-8656; Meeting ID: 988 4150 0923)
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
|
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 87757)
12:15 PM | Dr. Weinberg – Protocol Writing Series #5 | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)
|
|
8:00 AM | Thoracic Tumor Board – Thoracic Fellow | Podium A / Zoom
9:00 AM | Thoracic Research Meeting – Thoracic Fellow | Podium A / Microsoft Teams
12:15 PM | Dr. Dawson – Testicular Cancer | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
|
|
9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams
12:15 PM | Dr. Dunleavy – BTK Inhibitor Update | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)
1:00 PM | Pancreas Tumor Boar d | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
Connect with Georgetown Lombardi on Social Media |
|
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. |
|
|
|
|
|
|
